Clinical Edge Journal Scan

Meta-analysis reveals increased risk for thyroid dysfunction in patients with RA


 

Key clinical point: Patients with rheumatoid arthritis (RA) were at an increased risk of developing all types of thyroid dysfunctions, with the risk being the highest for hypothyroidism, followed by subclinical hypothyroidism, subclinical hyperthyroidism, and hyperthyroidism.

Major finding: Patients with RA vs non-RA control individuals were at a higher risk of developing thyroid dysfunctions such as hypothyroidism (pooled OR [pOR] 2.25; 95% CI 1.78-2.84), subclinical hypothyroidism (pOR 2.18; 95% CI 1.32-3.61), subclinical hyperthyroidism (pOR 2.13; 95% CI 1.25-3.63), and hyperthyroidism (OR 1.65; 95% CI 1.24-2.19).

Study details: Findings are from a systematic review and meta-analysis of 29 studies that evaluated thyroid dysfunction in patients with RA (n = 35,708) and non-RA control individuals (n = 149,421).

Disclosures: This study was supported by grants from the Science and Technology Bureau of Quanzhou and the Natural Science Foundation of Fujian Province. The authors declared no conflict of interests.

Source: Liu Y-j et al. Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review. Front Endocrinol . 2022;13:1015516 (Oct 13). Doi: 10.3389/fendo.2022.1015516

Recommended Reading

Doctors urge screening for autoimmune disorders for patients with celiac disease
MDedge Rheumatology
Opioids increase risk for all-cause deaths in RA vs. NSAIDs
MDedge Rheumatology
StopRA trial: Hydroxychloroquine doesn’t prevent or delay onset of rheumatoid arthritis
MDedge Rheumatology
Celiac disease linked to higher risk for rheumatoid arthritis, juvenile idiopathic arthritis
MDedge Rheumatology
New ACR vaccination guideline: Take your best shot
MDedge Rheumatology
Treatment intensification benefits early RA nonresponders in COBRA treat-to-target trial
MDedge Rheumatology
Tocilizumab more effective than etanercept in suppressing progression of joint erosion in RA
MDedge Rheumatology
Seropositive RA: A strong risk factor for lung cancer
MDedge Rheumatology
Aging associated with seronegative RA in women
MDedge Rheumatology
Red blood cell distribution width: An effective diagnostic biomarker for RA
MDedge Rheumatology